BIOMAT Database Logo BIOMAT Database Logo

Benzothieno[3,2-e][1,2,4]triazolo[4,3-c]pyrimidines: synthesis, characterization, antimicrobial activity, and incorporation into solid lipid nanoparticles. 2011

Shridhar I Panchamukhi, and Jameel Ahmed S Mulla, and Nitinkumar S Shetty, and Mohammed Iqbal A Khazi, and Ashraf Y Khan, and Mallikarjun B Kalashetti, and Imitiyaz Ahmed M Khazi
Department of Chemistry, Karnatak University, Dharwad, India.

Fused triazolothienopyrimidines were prepared from the corresponding 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile. These precursors were intern prepared by employing the Gewald's reaction. All the newly synthesized compounds were characterized by spectral and analytical data. Title compounds displayed promising antibacterial and antifungal activities. Compound 3h which exhibited good antimicrobial activity was incorporated into SLN and characterized for particle size, entrapment efficiency (EE%), scanning electron microscopy (SEM), differential scanning calorimetry (DSC) and in-vitro release studies. It showed narrow particle size distribution with high entrapment efficiency. In-vitro release study of compound loaded SLNs in phosphate buffer of pH 7.4, exhibited a biphasic pattern with an initial burst and prolonged release over 24 h.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008855 Microscopy, Electron, Scanning Microscopy in which the object is examined directly by an electron beam scanning the specimen point-by-point. The image is constructed by detecting the products of specimen interactions that are projected above the plane of the sample, such as backscattered electrons. Although SCANNING TRANSMISSION ELECTRON MICROSCOPY also scans the specimen point by point with the electron beam, the image is constructed by detecting the electrons, or their interaction products that are transmitted through the sample plane, so that is a form of TRANSMISSION ELECTRON MICROSCOPY. Scanning Electron Microscopy,Electron Scanning Microscopy,Electron Microscopies, Scanning,Electron Microscopy, Scanning,Electron Scanning Microscopies,Microscopies, Electron Scanning,Microscopies, Scanning Electron,Microscopy, Electron Scanning,Microscopy, Scanning Electron,Scanning Electron Microscopies,Scanning Microscopies, Electron,Scanning Microscopy, Electron
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002152 Calorimetry, Differential Scanning Differential thermal analysis in which the sample compartment of the apparatus is a differential calorimeter, allowing an exact measure of the heat of transition independent of the specific heat, thermal conductivity, and other variables of the sample. Differential Thermal Analysis, Calorimetric,Calorimetric Differential Thermal Analysis,Differential Scanning Calorimetry,Scanning Calorimetry, Differential
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D053758 Nanoparticles Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging. Nanocrystalline Materials,Nanocrystals,Material, Nanocrystalline,Materials, Nanocrystalline,Nanocrystal,Nanocrystalline Material,Nanoparticle

Related Publications

Shridhar I Panchamukhi, and Jameel Ahmed S Mulla, and Nitinkumar S Shetty, and Mohammed Iqbal A Khazi, and Ashraf Y Khan, and Mallikarjun B Kalashetti, and Imitiyaz Ahmed M Khazi
Synthesis, Characterization and Cytotoxicity of Substituted [1]Benzothieno[3,2-e][1,2,4]triazolo [4,3-a]pyrimidines.
January 2017, Acta chimica Slovenica,
Shridhar I Panchamukhi, and Jameel Ahmed S Mulla, and Nitinkumar S Shetty, and Mohammed Iqbal A Khazi, and Ashraf Y Khan, and Mallikarjun B Kalashetti, and Imitiyaz Ahmed M Khazi
Synthesis and electrophilic substitutions of novel pyrazolo[1,5-c]-1,2,4-triazolo[4,3-a]pyrimidines.
August 2011, Molecules (Basel, Switzerland),
Shridhar I Panchamukhi, and Jameel Ahmed S Mulla, and Nitinkumar S Shetty, and Mohammed Iqbal A Khazi, and Ashraf Y Khan, and Mallikarjun B Kalashetti, and Imitiyaz Ahmed M Khazi
Synthesis and antimicrobial activity of acyclo C-nucleosides: 3-(alditol-1-yl)-7-oxo-5-phenyl-1,2,4-triazolo[4,3-a]pyrimidines.
February 2000, Die Pharmazie,
Shridhar I Panchamukhi, and Jameel Ahmed S Mulla, and Nitinkumar S Shetty, and Mohammed Iqbal A Khazi, and Ashraf Y Khan, and Mallikarjun B Kalashetti, and Imitiyaz Ahmed M Khazi
Three Component One-Pot Synthesis and Antiproliferative Activity of New [1,2,4]Triazolo[4,3-a]pyrimidines.
May 2023, Molecules (Basel, Switzerland),
Shridhar I Panchamukhi, and Jameel Ahmed S Mulla, and Nitinkumar S Shetty, and Mohammed Iqbal A Khazi, and Ashraf Y Khan, and Mallikarjun B Kalashetti, and Imitiyaz Ahmed M Khazi
Water-soluble pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as human A₃ adenosine receptor antagonists.
June 2012, Journal of medicinal chemistry,
Shridhar I Panchamukhi, and Jameel Ahmed S Mulla, and Nitinkumar S Shetty, and Mohammed Iqbal A Khazi, and Ashraf Y Khan, and Mallikarjun B Kalashetti, and Imitiyaz Ahmed M Khazi
Synthesis and Antimicrobial Activity of Some New Thiadiazoles, Thioamides, 5-Arylazothiazoles and Pyrimido[4,5-d][1,2,4]triazolo[4,3-a]pyrimidines.
August 2016, Molecules (Basel, Switzerland),
Shridhar I Panchamukhi, and Jameel Ahmed S Mulla, and Nitinkumar S Shetty, and Mohammed Iqbal A Khazi, and Ashraf Y Khan, and Mallikarjun B Kalashetti, and Imitiyaz Ahmed M Khazi
Pyrimidines. Part II: Synthesis of novel pyrimidines, 1,2,4-triazolo[4,3-a]pyrimidin-7-ones and pyrimidino[2,1-c][1,2,4]triazin-8-ones for their antimicrobial and anticancer activities.
November 2003, Bollettino chimico farmaceutico,
Shridhar I Panchamukhi, and Jameel Ahmed S Mulla, and Nitinkumar S Shetty, and Mohammed Iqbal A Khazi, and Ashraf Y Khan, and Mallikarjun B Kalashetti, and Imitiyaz Ahmed M Khazi
Synthesis, biological activity and molecular modeling study of novel 1,2,4-triazolo[4,3-b][1,2,4,5]tetrazines and 1,2,4-triazolo[4,3-b][1,2,4]triazines.
April 2020, Scientific reports,
Shridhar I Panchamukhi, and Jameel Ahmed S Mulla, and Nitinkumar S Shetty, and Mohammed Iqbal A Khazi, and Ashraf Y Khan, and Mallikarjun B Kalashetti, and Imitiyaz Ahmed M Khazi
Synthesis of Novel Pyrido[4,3-e][1,2,4]triazino[3,2-c][1,2,4]thiadiazine 6,6-dioxide Derivatives with Potential Anticancer Activity.
December 2015, Molecules (Basel, Switzerland),
Shridhar I Panchamukhi, and Jameel Ahmed S Mulla, and Nitinkumar S Shetty, and Mohammed Iqbal A Khazi, and Ashraf Y Khan, and Mallikarjun B Kalashetti, and Imitiyaz Ahmed M Khazi
Organoiodine(III) mediated synthesis of 3,9-diaryl- and 3,9-difuryl-bis-1,2,4-triazolo[4,3-a][4,3-c]pyrimidines as antibacterial agents.
June 2007, European journal of medicinal chemistry,
Copied contents to your clipboard!